1.Characterization of proteins in hyperlipidemia pancreas using differential gel electrophoresis and tandem mass spectrometry
Wei ZHANG ; Xingpeng WANG ; Zhuowei YU ; Yue ZHU ; Xiaofeng YU ; Kai WU ; Yue ZENG ; Mingyi XU
Chinese Journal of Pancreatology 2008;8(2):101-104
Objective To investigate the mechanism of hypedipidemia on pancreas of rats by comparative proteomic analysis.Methods Ten male SD rats were randomly divided into two groups,the experimental group Was fed with high lipid forage and the control group Was fed with normal food.Pancreatic samples from the two groups were harvested six weeks later.Differential protein analysis Was performed using differential in-gel electrophoresis(DIGE),and characterizing the protein biomarkers using tandem mass spectrometry.Western blot Was used to confirm the expression of significantly changed proteins.Results Compared to the normal pancreas tissue,a total of 3 protein spot-features were found to be significantly increased and 11 significantly decreased in pancreatic samples with hyperlipidemia.Significantly increased proteins in hyperlipidemia pancreatic samples were arginaseⅡ,ribonuclease inhibitor and glyeine amidinotransferase,which increased by 2.19,1.82 and 1.12 fold,respectively.Significantly decreased proteins in hyperlipidemia group were tyrosyl-tRNA synthetase,alpha-amylase,triacylglycerol lipase,DJ-1protein,Cu,Zn superoxide dismutase,which dicreased by 2.48,2.37,1.85,1.73 and 1.65 folds,respectively.Western blot analysis revealed increased arginase Ⅱ levels and decreased alpha-amylase in pancreatic samples with hyperlipidemia.Conclusions Pancreas wag possibly injured by hyperlipidemia via increase of arginase Ⅱ.Decreased amylase and lipase may be the protection mechanism of pancreas.
2.Status investigation and influencing factors of self-care ability of patients after sacral neuromodulation in the first stage
Qingqing DING ; Yao ZHAO ; Ziyu DING ; Jiajia LI ; Zhuowei WU ; Huifan LIU
Chinese Journal of Modern Nursing 2022;28(24):3288-3292
Objective:To investigate the status quo of self-care ability of patients after sacral neuromodulation in the first stage, and analyze its influencing factors.Methods:The convenient sampling method was used to select 106 patients after sacral neuromodulation in the first stage who were admitted to Department of Urology in the First Affiliated Hospital of Zhengzhou University from July 2019 to July 2021. Questionnaires were carried out using general information questionnaire, Exercise of Self-Care Agency Scale (ESCA) and Self-efficacy for Chronic Disease 6-Item Scale (SECD6) . The t test, one-way ANOVA, Pearson correlation analysis and multiple linear regression analysis were used to explore the influencing factors of self-care ability. Results:The self-care ability score of the first stage patients after sacral neuromodulation was (80.07±21.39) , including 9 cases (8.5%) with high level, 81 cases (76.4%) with medium level and 16 cases (15.1%) with low level. There were statistically significant differences in the self-care ability scores of patients with different occupational status, medical insurance type, place of residence, residence status, educational level and per capita monthly income of the family ( P<0.05) . The total score and each dimension score of patients' self-care ability were positively correlated with the self-efficacy score ( P<0.05) . The results of multiple linear regression analysis showed that occupational status, educational level, per capita monthly family income and self-efficacy were the main influencing factors of self-care ability of patients after sacral neuromodulation in the first stage ( P<0.05) . Conclusions:The self-care ability of the first stage patients after sacral neuromodulation is generally at a moderate level and the self-care ability of patients needs to be further improved, especially the self-care skills need to be strengthened. Nursing staff should give patients individualized health guidance according to different influencing factors to help them improve their self-care ability.
3.Assessment and application of tumor regression grade after neoadjuvant chemotherapy in bladder cancer
Suhua WU ; Jingwei YE ; Yijun ZHANG ; Ping YANG ; Yunlin YE ; Xiangdong LI ; Kai YAO ; Zhuowei LIU ; Yun CAO
Chinese Journal of Urology 2023;44(11):823-829
Objective:To verify the prognostic significance of the tumor regression grade (TRG) for muscle-invasive bladder cancer (MIBC) patients undergoing radical cystectomy (RC) after neoadjuvant chemotherapy.Methods:The data of 70 MIBC patients treated with gemcitabine combined with cisplatin neoadjuvant chemotherapy and RC in Sun Yat-sen University Cancer Center between July 2016 to November 2021 were retrospectively reviewed. There were 65 males and 5 females, with an average age(59.79±10.56)years old. The patients accepted transurethral resection of bladder tumor (TURBT) specimens before neoadjuvant chemotherapy. Clinicopathological characteristics of patients were recorded and TRG was assessed. TRG evaluation criteria: TRG 1 was defined as no cancer residue, TRG 2 was defined as the proportion of residual cancer area to tumor bed area <50%, and TRG 3 was defined as the proportion of residual cancer area to the area of the tumor bed ≥ 50%. Chi-square test or Fisher's exact test were used to compare the relationship between patients' clinicopathological characteristics and TRG. The relationship between post-neoadjuvant therapy tumor and node(ypTN)stage, and survival, including overall survival(OS)and recurrence-free survival (RFS) were analyzed by Kaplan-Meier analysis. The pathologically locally descending disease was defined as (ypT < T 2 and ypN=N 0) and pathologically locally advanced disease was defined as (ypT≥T 2 and/or ypN ≥N 1). Cox regression was used for univariate and multivariate analysis of OS and RFS. Results:Chi-square test or Fisher exact test analysis showed TRG was significantly associated with ypT stage ( P < 0.001), ypN stage ( P = 0.002), lympho-vascular invasion ( P<0.001) and variant histology ( P<0.001). The OS of patients with TRG 1, TRG 2 and TRG 3 were 20.5(10.3, 31.8), 17.0(11.0, 30.8)and 15.0(11.0, 26.0) months, respectively, and the difference was significantly different( P = 0.037). The RFS of patients with TRG 1, TRG 2 and TRG 3 were 15.0(8.3, 25.5), 15.0(8.0, 27.0)and 11.0(4.5, 25.5) months, respectively, and the difference was significantly different ( P=0.029). There were significant differences between patients with pathologically locally descending disease and locally advanced disease in OS [18.5(10.3, 30.8)vs.15.0(11.0, 27.3)months, P = 0.013] and RFS [14.0(8.0, 24.0)vs. 11.5(8.0, 26.8)months, P = 0.012]. Among patients with locally advanced pathology, the OS was 19.5(11.0, 32.5)months for patients with TRG ≤2, 13.5(10.8, 26.0)months for patients with TRG 3( P=0.140). The RFS was 12.0(8.0, 31.0)months for those patients with TRG ≤2 and 11.0(6.0, 26.0)months for those patients with TRG 3( P = 0.180). Cox univariate analyses showed that patients with TRG 3 were associated with decreased OS ( HR = 6.043, 95% CI 1.170-31.213, P = 0.032) and RFS ( HR = 6.354, 95% CI 1.231-31.802, P = 0.027). Conclusions:This study showed that TRG was correlated with OS and RFS among patients. The patients who had the higher TRG had the worse prognosis. It was confirmed that TRG predicted the prognosis of patients undergoing radical cystectomy after neoadjuvant chemotherapy. Therefore, TRG assessment is recommend in pathology report for patients who had radical cystectomy after neoadjuvant chemotherapy.
4.Application of holographic image navigation in urological laparoscopic and robotic surgery
Gang ZHU ; Jinchun XING ; Guobin WENG ; Zhiquan HU ; Ningchen LI ; He ZHU ; Pingsheng GAO ; Zhihua WANG ; Weizhi ZHU ; Kai ZHANG ; Hongbo LI ; Zhun WU ; Rui ZHU ; Xifeng WEI ; Yanan WANG ; Qun XIE ; Bing FU ; Xinghuan WANG ; Lin QI ; Xin YAO ; Tiejun PAN ; Delin WANG ; Nan LIU ; Jianguang QIU ; Jianggen YANG ; Bao ZHANG ; Zhuowei LIU ; Hui HAN ; Gang LI ; Bin ZHANG ; Manli NA ; Jingjing LU ; Lei WANG ; Zichen ZHAO ; Yanqun NA
Chinese Journal of Urology 2020;41(2):131-137
Objective To evaluate the clinical value of holographic image navigation in urological laparoscopic and robotic surgery.Methods The data of patients were reviewed retrospectively for whom accepted holographic image navigation laparoscopic and robotic surgery from Jan.2019 to Dec.2019 in Beijing United Family Hospital and other 18 medical centers,including 78 cases of renal tumor,2 cases of bladder cancer,2 cases of adrenal gland tumor,1 cases of renal cyst,1 case of prostate cancer,1 case of sweat gland carcinoma with lymph node metastasis,1 case of pelvic metastasis after radical cystectomy.All the patients underwent operations.In the laparoscopic surgery group,there were 27 cases of partial nephrectomy,1 case of radical prostatectomy,2 cases of radical cystectomy and 2 cases of adrenalectomy.In the da Vinci robotic surgery group of 54 cases,there were 51 cases of partial nephrectomy,1 case of retroperitoneal lymph node dissection,1 case of retroperitoneal bilateral renal cyst deroofing and 1 case of resection of pelvic metastasis.There were 41 partial nephrectomy patients with available clinical data for statistic,with a median age of 53.5 years (range 24-76),including 26 males and 15 females.The median R.E.N.A.L score was 7.8 (range 4-11).Before the operation,the engineers established the holographic image based on the contrast CT images and reports.The surgeon applied the holographic image for preoperative planning.During the operation,the navigation was achieved by real time fusing holographic images with the laparoscopic surgery images in the screen.Results All the procedures had been complete uneventfully.The holographic images helped surgeon in understanding the visual three-dimension structure and relation of vessels supplying tumor or resection tissue,lymph nodes and nerves.By manipulating the holographic images extracorporeally,the fused image guide surgeons about location vessel,lymph node and other important structure and then facilitate the delicate dissection.For the 41 cases with available clinical data including 23 cases of robotic-assisted partial nephrectomy and 18 cases of laparoscopic nephrectomy,the median operation time was 140 (range 50-225) min,the median warm ischemia time was 23 (range 14-60) min,the median blood loss was 80(range 5-1 200) ml.In the robotic surgery group,the median operation time was 140 (range 50-215)min,the median warm i schemia time was 21 (range 17-40)min,the median blood loss was 150(range 30-1 200)ml.In the laparoscopic surgery group,the median operation time was 160(range 80-225)min,the median warm ischemia time was 25 (range 14-60)min,the median blood loss was 50 (range 5-1 200) ml.All the patients had no adjacent organ injury during operation.There were 2 cases with Clavien Ⅱ complications.One required transfusion and the other one suffered hematoma post-operation.However,the tumors were located in the renal hilus for these 2 cases and the R.E.N.A.L scores were both 11.Conclusions Holographic image navigation can help location and recognize important anatomic structures during the surgical procedures..This technique will reduce the tissue injury,decrease the complications and improve the success rate of surgery.